This information is intended for healthcare providers, who may have interest in furthering research and development with PENFS as well as payors, and investors, who are seeking information about the product to help them make their own decisions, on a case by case basis about coverage, only.  Please note, the research being described may include information about technology and intended uses of that technology which have not been reviewed or approved/cleared by the U.S. FDA, and is being provided for informational purposes only.  NeurAxis does not recommend or suggest the use of its PENFS IB-Stim device for uses beyond those that are cleared by the U.S. FDA.

For Important information about IB-Stim, including IFU, risks, warnings and precautions, see: https://ibstim.com/important-information/